Future Events
full calendarEURL ECVAM
ESTIV: ASCCTTox.org/AnnualMeeting
Join scientists from across government, industry, academia, and NGOs to share science, discuss regulatory policies, and collaborate to advance toxicology…
Call for Abstracts ESTIV 2026!
We are pleased to announce that abstract submission for the 23rd International Congress of the European Society of Toxicology In Vitro (ESTIV 2026), is now possible!The general theme of the congress is “Ensuring Safety, Advancing Science: Bridging to the Future with NAMs”.
Provisionally accepted sessions for the ESTIV 2026 Congress
We are pleased to announce that the Scientific Committee of the ESTIV2026 Congress has provisionally accepted 25 session proposals for the upcoming ESTIV 2026 Congress, which will take place in Maastricht, The Netherlands. With over 50 high-quality submissions received in the initial round, this marks an exciting milestone on the road to ESTIV’s flagship event.
Group working on improving the AOP framework and the AOP-Wiki publishes activity report
The Society for the Advancement of AOPs Knowledgebase Interest Group (SKIG) has recently issued its activity report, reflecting the ongoing contributions and future plans of this vibrant assembly of over 40 international experts.
ESTIV-ASCCT Award Winners Series: Gabriela De Oliveira Prado Correa, Sezin Aday Aydin, and Amber Daniel
We hope you will join us on April 24, 2025, for the next installment of our 2025 Award Winners Webinar Series…
MECC Maastricht Highlights ESTIV 2026 Conference
We are pleased to share that MECC Maastricht has published an article about the upcoming ESTIV 2026 Conference….
ESTIV – ASCCT Award Winners Series: Madison Feshuk, Bhaja Padhi, and Rachel Broughton
We hope you will join us on March 11, 2025, for the next installment of our 2025 Award Winners Webinar Series…
Freelance Editor-in-Chief — Contract for Services
A freelance contract opportunity has arisen for an experienced Editor-in-Chief to join the existing ATLA team of Managing Editor, Technical Editor and Associate Editors for an initial period of three years, including a six-month trial.